Prof. Dr. Khalid Umer Khayyam | Tuberculosis | Best Researcher Award
Consultant Epidemiologist, National Institute of Tuberculosis and Respiratory Diseaes, India
Prof. (Dr.) Khalid Umer Khayyam is a distinguished Consultant Epidemiologist currently serving at the National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi. With over two decades of experience in community medicine, public health, and epidemiological research, Dr. Khayyam has contributed extensively to India’s fight against tuberculosis and other respiratory diseases. His extensive academic background, practical interventions in disease elimination programs, and national-level training initiatives have placed him at the forefront of public health leadership.
Professional Profile
🎓 Education
Dr. Khayyam holds an MBBS and MD in Community Medicine, supplemented with multiple postgraduate diplomas including PGCTDC, PGDHHM, PGDMCH, PGDGM, and an MBA. He is also recognized internationally as a Fellow of the College of Chest Physicians (FCCP) and the Royal Society for Public Health (FRSH), London. His multidisciplinary academic training empowers him to address complex health challenges from medical, managerial, and epidemiological perspectives.
👨⚕️ Experience
Dr. Khayyam’s professional journey spans consultancy roles in health education, biostatistics, and social welfare. At NITRD, he has supervised 55 academic theses across MD, DNB, MPH, MSc, DHA, and PhD programs, supporting institutional and inter-institutional research. He is also responsible for peer assessments under the government’s Kaya Kalp initiative. His leadership in organizing TB and COVID-19 awareness campaigns, especially in underserved communities, reflects his commitment to inclusive public health. As part of the National Tuberculosis Elimination Programme (NTEP), he oversees several Designated Microscopy Centres and DOT centres, achieving a consistent 90% treatment success and conversion rate.
🔬 Research Interests
Dr. Khayyam’s research is grounded in respiratory epidemiology, tuberculosis control strategies, health education, and public health policy implementation. He is actively involved in over 30 research projects and multicentric studies, focusing on the operational aspects of TB management, patient behavior, disease burden estimation, and chronic disease co-morbidities. His work bridges clinical insight and field epidemiology to develop community-based interventions.
🏅 Awards & Honors
In recognition of his service, Dr. Khayyam was honored with the Bharat Jyoti Award and the Best Citizen of India Award in 2006. His affiliation with professional societies—such as the Delhi Medical Association, Academy of Hospital Administration, and international organizations—reflects his global engagement in advancing public health.
📚 Publications Top Notes
Risk Factors of Treatment Interruptions Among Drug-Sensitive and Drug-Resistant Pulmonary Tuberculosis Patients – A Study from South Delhi
Published in: Indian Journal of Tuberculosis, 2024
Cited by: 1 article
Summary: This study analyzes socioeconomic and systemic barriers affecting treatment continuity in TB patients, offering data-driven solutions for improved adherence in urban health settings.
Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments
Published: 2023
Cited by: 7 articles
Summary: A comprehensive review discussing genetic predisposition and evolving treatment modalities in rheumatoid arthritis, with implications for co-infection management in TB patients.
🧾 Conclusion
Prof. (Dr.) Khalid Umer Khayyam stands as a committed physician, educator, and public health leader whose work continues to shape India’s response to communicable diseases. His dual role as a practicing epidemiologist and academic mentor bridges clinical practice with policy formulation. Through over 80 publications, impactful community interventions, and national-level capacity building, Dr. Khayyam exemplifies excellence in service and scholarship. His achievements merit strong consideration for awards recognizing dedication to public health innovation and leadership.